The problem: peptides are fragile
A peptide is a chain of amino acids held together by peptide bonds. The digestive tract is, in effect, a machine for breaking exactly those bonds. Stomach acid denatures the chain; intestinal proteases cleave it; what little survives faces first-pass metabolism in the liver. For most therapeutic peptides, oral bioavailability sits under five percent — meaning ninety-five-plus percent never reaches circulation intact.
That is the whole reason the needle exists. Subcutaneous injection bypasses the gut entirely and delivers seventy to ninety-five percent of the dose to circulation, with a predictable absorption curve a physician can dose against.
The routes, honestly compared
Subcutaneous injection is the standard because it is predictable and efficient. Intranasal delivery works for a handful of small, stable peptides — selank and semax are the common examples — trading lower bioavailability for genuine convenience. Oral formulations exist but are the exception, requiring either an unusually stable molecule or specialized delivery chemistry; the GLP-1 oral tablet is a heavily engineered case, not a template.
Transdermal creams are where most consumer marketing overreaches. Peptides large enough to be therapeutic are usually too large to cross intact skin in meaningful quantity. A topical GHK-Cu for local skin effect is plausible; a transdermal cream promising systemic GH-axis effects generally is not.
| Route | Bioavailability | Best for | Watch for |
|---|---|---|---|
| Subcutaneous | 70-95% | Most therapy peptides | Injection technique, sterility |
| Intranasal | 10-40% | Small stable peptides (selank, semax) | Lower, variable exposure |
| Oral | <5% | Rare engineered formulations | Marketing claims outrunning chemistry |
| Transdermal | <10% | Local skin effect only | Systemic claims are usually false |
The needle is smaller than you think
The anxiety about injection is almost always worse than the act. Subcutaneous peptide injections use an insulin-style fine-gauge needle into the fat of the abdomen or thigh — shallow, quick, and for most people close to painless once the first one is behind them.
Our separate guide on subcutaneous technique walks through the clean, anxiety-free routine step by step. The point here is narrower: do not choose an inferior route to avoid a needle that most patients stop noticing within a week.
Bottom line
Route follows chemistry. Injection wins for most peptides because it is the only route that reliably delivers the dose; intranasal is a real option for a few small molecules; oral and transdermal are legitimate in narrow cases and oversold everywhere else. When a product promises a hard-to-deliver peptide in an easy-to-take format, that is the claim to check first — ideally with a physician who has no reason to sell you the convenient version.
Share